Pergament & Cepeda LLP
Mr. Pergament litigates patent infringement actions and drafts patent opinions for a variety of pharmaceutical clients from India, China, Russia, and North America. Mr. Pergament primary expertise is in positioning pharmaceutical assets versus patent portfolios, both offensively and defensively, by any means available under the law, including patent litigation, patent strategy considerations, and patent procurement. Mr. Pergament has a broad legal, business and technical expertise in pharmaceutical and cosmetic industry. At present, Mr. Pergament’s practice is focused mainly on pharmaceutical patent litigation and establishing litigation positions for generic pharmaceutical companies, and on counseling brand side clients in pharmaceutical and chemical industries with respect to life cycle management and other strategic issues, including portfolio management. Mr. Pergament was a scientist, an attorney, and an executive with several major pharmaceutical companies, and he has hand-on understanding of legal, business, and technical issues facing a broad range of pharmaceutical products, including NCEs, specialty, generics, formulations, and pharmaceutical solids.
Admissions: New York, 2000, New Jersey, 2001; U.S. Court of Appeals for the Federal Circuit; registered to practice before U.S. Patent and Trademark Office (1997).
Education: University of Odessa, former USSR (B.Sc., Chemistry/Organic Chemistry, 1985); Case Western Reserve University (M.Sc., Chemistry/Organic Chemistry, 1993); Rutgers School of Law, cum laude, Order of the Coif (J.D., 1999).
Practice Areas: Pharmaceutical Patent Litigation, Pharmaceutical Patent Law, and Counseling